Brind.

TD Cowen cut Passage Bio's stock rating to hold on August 10, 2026.

4 reports, 2 independent Updated Mon 00:00
No new developments lately
Reports
4
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

TD Cowen cut Passage Bio's stock rating to hold on August 10, 2026.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Passage Bio receives MarketBeat consensus ratings and is listed on Nasdaq.1 source
  2. TD Cowen lowered its rating on Passage Bio, Inc.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
2 more outlets ran the same wire story